amiodarone has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of macrovesicular steatosis, cellular ballooning, and inflammation." | 2.48 | A myriad of pathways to NASH. ( Larrain, S; Rinella, ME, 2012) |
| "Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive deposition of droplets in hepatocytes." | 1.51 | Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats. ( Eguchi, A; Ichikawa, R; Masuda, S; Mizukami, S; Nakamura, K; Nakamura, M; Okada, R; Shibutani, M; Tanaka, T; Yoshida, T, 2019) |
| "Amiodarone is a highly effective treatment for supraventricular and ventricular tachyarrhythmia; however, it could be associated with several serious adverse effects, including liver injury." | 1.48 | Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports. ( Hayashi, K; Kawashiri, MA; Kurose, N; Nishida, N; Oyama, T; Sakata, K; Sasaki, M; Sawada, T; Tada, H; Tanaka, Y; Tsuda, T; Yamagishi, M; Yoshida, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuda, T | 1 |
| Tada, H | 1 |
| Tanaka, Y | 1 |
| Nishida, N | 1 |
| Yoshida, T | 2 |
| Sawada, T | 1 |
| Sakata, K | 1 |
| Hayashi, K | 1 |
| Kawashiri, MA | 1 |
| Oyama, T | 1 |
| Sasaki, M | 1 |
| Kurose, N | 1 |
| Yamagishi, M | 1 |
| Masuda, S | 1 |
| Mizukami, S | 1 |
| Eguchi, A | 1 |
| Ichikawa, R | 1 |
| Nakamura, M | 1 |
| Nakamura, K | 1 |
| Okada, R | 1 |
| Tanaka, T | 1 |
| Shibutani, M | 1 |
| von Vital, JM | 1 |
| Karachristos, A | 1 |
| Singhal, A | 1 |
| Thomas, R | 1 |
| Jain, A | 1 |
| Larrain, S | 1 |
| Rinella, ME | 1 |
1 review available for amiodarone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
A myriad of pathways to NASH.
Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Disea | 2012 |
3 other studies available for amiodarone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
Topics: Aged; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aspartate Aminotransferases; Chemica | 2018 |
Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats.
Topics: Amiodarone; Animals; Autophagosomes; Autophagy; Autophagy-Related Protein 5; Chloroquine; Diet, High | 2019 |
Acute amiodarone hepatotoxicity after liver transplantation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Hepatocellular; C | 2011 |